arginine vasopressin has been researched along with metoprolol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dahlöf, C; Franco-Cereceda, A; Lundberg, JM | 1 |
| Deng, LY; Schiffrin, EL | 1 |
| Burrin, JM; Hall, GM; Loughnan, BA; Matson, AM; Shaw, M | 1 |
| Colombari, E; Lopes, OU; Menani, JV; Sato, MA | 1 |
| Huang, K; Li, Q; Lu, S; Ma, T; Tang, S; Wu, M; Yang, H; Zhong, J | 1 |
1 review(s) available for arginine vasopressin and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine vasopressin and metoprolol
| Article | Year |
|---|---|
Pituitary-adrenal, hormonal changes during induced hypotension with labetol or isoflurane for middle-ear surgery.
Topics: Adrenal Cortex Hormones; Adrenergic Antagonists; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Aldosterone; Analysis of Variance; Anesthetics, Inhalation; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Ear, Middle; Follow-Up Studies; Humans; Hydrocortisone; Hypotension, Controlled; Injections, Intravenous; Isoflurane; Labetalol; Metoprolol; Oxygen; Pituitary Hormones; Pituitary-Adrenal System; Sample Size | 1998 |
6 other study(ies) available for arginine vasopressin and metoprolol
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
Topics: Animals; Arginine Vasopressin; Atropine; Coronary Vessels; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Metoprolol; Muscle, Smooth, Vascular; Myocardial Contraction; Nerve Tissue Proteins; Neuropeptide Y; Nifedipine; Norepinephrine; Phentolamine; Tetrodotoxin | 1985 |
Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats.
Topics: Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Body Weight; Cilazapril; Dose-Response Relationship, Drug; Endothelins; Heart Rate; Hydralazine; Hypertension, Renovascular; In Vitro Techniques; Mesenteric Artery, Inferior; Metoprolol; Muscle, Smooth, Vascular; Norepinephrine; Rats; Rats, Sprague-Dawley; Renin | 1993 |
Enhanced pressor response to carotid occlusion in commNTS-lesioned rats: possible efferent mechanisms.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arginine Vasopressin; Blood Pressure; Carotid Arteries; Chemoreceptor Cells; Constriction; Efferent Pathways; Electrolysis; Male; Metoprolol; Phenylephrine; Potassium Cyanide; Prazosin; Pressoreceptors; Rats; Rats, Wistar; Solitary Nucleus | 2000 |
Metoprolol Protects Against Arginine Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by Regulating the Sirt1/p53/p21 Axis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylation; Adrenergic beta-1 Receptor Antagonists; Animals; Arginine Vasopressin; Cell Line; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cytokines; DNA Damage; Metoprolol; Myocytes, Cardiac; NAD; NADP; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Protein Processing, Post-Translational; Rats; Signal Transduction; Sirtuin 1; Telomerase; Tumor Suppressor Protein p53 | 2022 |